Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Plasma fasting glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Plasma 2-hr post-prandial glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Urine glucose chemical titer measurement |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Blood glucose tolerance |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Blood sugar tolerance |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluid sample glucose measurement (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lunch time blood sugar measurement (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Supper time blood sugar measurement (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Bedtime blood sugar measurement (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
BM stix glucose measurement |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
60 minute blood glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
120 minute blood glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
90 minute blood glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
150 minute blood glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
30 minute plasma glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
60 minute plasma glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
120 minute plasma glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
150 minute plasma glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
30 minute serum glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
60 minute serum glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
120 minute serum glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
30 minute blood glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
90 minute plasma glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
90 minute serum glucose measurement |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
150 minute serum glucose measurement |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glucose tolerance test NOS |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose [endocrine] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose 5% bladder irrigation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Parenteral glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glucose powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glucose 10% infusion solution bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose 15% infusion solution bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose 20% infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose 40% infusion (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose 50% infusion solution bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose 5% infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose 50% prefilled syringe (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose 70% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Faecal clinitest (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Urine clinitest (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing glucose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Compound sodium lactate half strength/glucose 5% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Compound sodium lactate infusion solution bag (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Compound sodium lactate half strength infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 10mmol/glucose 5% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 13.5mmol/glucose 5% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20mmol/glucose 5% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20mmol/glucose 5% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 27mmol/glucose 5% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 40mmol/glucose 5% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alpha-glucosidase-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bupivacaine 0.5%+glucose injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing bupivacaine and glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Compound sodium lactate infusion solution 500 mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Compound sodium lactate infusion solution 1 L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose 10% infusion solution 500 mL polyethylene bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose 10% infusion solution 1 L polyethylene bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose 20% infusion solution 500 mL polyethylene bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose 20% infusion solution 20 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose 50% infusion solution 20 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose 50% infusion solution 50 mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose 50% infusion solution 500 mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose 50% infusion solution 3 L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose 50% infusion solution 500 mL polyethylene bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose 5% infusion solution 100 mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose 5% infusion solution 150 mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose 5% infusion solution 250 mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose 5% infusion solution 1 L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fecal glucose level |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dialysis fluid glucose measurement (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Blood glucose series |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ascitic fluid glucose measurement (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Bupivacaine hydrochloride 7.5mg/dextrose 82.5mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lignocaine hydrochloride+glucose (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lignocaine hydrochloride+glucose 0.1%/5% infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lignocaine hydrochloride+glucose 0.2%/5% infusion (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lidocaine hydrochloride 0.4%/glucose 5% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lignocaine hydrochloride+glucose 0.6%/5% infusion (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lignocaine hydrochloride+glucose 0.2%/5% Polyfusor (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lignocaine hydrochloride+glucose 0.4%/5% Polyfusor (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lidocaine hydrochloride 5%/glucose 7.5% injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Caffeine+glucose (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing glucose and molasses (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Milrinone + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium chloride 0.9%/glucose 5% infusion solution 1 L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alcohol + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium chloride 0.9%/glucose 5% infusion solution 500 mL polyethylene bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose 400 mg/g oral gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 5g/100mL (5%) injection solution 25mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lactated Ringer's solution + 5% dextrose + 0.15% potassium hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 40mmol/dextrose 4%/saline 0.18% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cefoxitin + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 27mmol/dextrose 4%/saline 0.18% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose + potassium chloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing glucose and sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dextrose 5g/100mL (5%) injection solution 500mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Morphine sulfate + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium chloride 0.18%/glucose 5% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 30% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 5g/100mL (5%) injection solution 10mL syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium chloride 0.18%/glucose 4% infusion solution 1 L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|